| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $-1.4 (Miss by $-1.64) |
| EPS GAAP Actual | $-1.4 (Miss by $-1.64) |
| Revenue Actual | $0.062103B |
| Revenue Surprise | Beat by $62.103M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $0.064815062B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 0 |
| Dec 2028 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -1.4 | -1.4 | 0.062103B | 1.69% | -0.13M |
| FQ2 2025 (Jun 2025) | -0.0405 | -0.0405 | 0.062099B | 100% | -0.13M |
| FQ1 2025 (Mar 2025) | -0.0531 | -0.0531 | 0B | -INF% | 0M |
| FQ4 2024 (Dec 2024) | -0.0337 | -0.0337 | 0.061264B | 3.94% | 61.26M |
| FQ3 2024 (Sep 2024) | -0.0338 | -0.0338 | 0.061055B | 100% | 61.06M |
| FQ2 2024 (Jun 2024) | -0.0395 | -0.0395 | 0B | -INF% | 0M |
| FQ1 2024 (Mar 2024) | -0.0415 | -0.0415 | 0.059513B | 6.22% | 59.51M |
| FQ4 2023 (Dec 2023) | -0.0354 | -0.0354 | 0.058852B | 5.54% | 58.85M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.064815062B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 0 |
| FQ3 2026 (Jul 2026) | 0 | INF | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.07B | -- | 0.07B | 0.07B | 1 |
| FQ3 2027 (Sep 2027) | 0.06B | -- | 0.06B | 0.07B | 1 |
| FQ2 2027 (Jun 2027) | 0.07B | -- | 0.07B | 0.07B | 1 |
| FQ1 2027 (Mar 2027) | 0.07B | -- | 0.06B | 0.07B | 1 |
| FQ4 2026 (Oct 2026) | 0.07B | -- | 0.07B | 0.07B | 1 |
| FQ3 2026 (Jul 2026) | 0.07B | 5.68 | 0.07B | 0.07B | 1 |
| FQ2 2026 (Jun 2026) | 0.07B | 5.69 | 0.06B | 0.07B | 1 |
| FQ1 2026 (Mar 2026) | 0.06B | -- | 0.06B | 0.07B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
2
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | -1.4 | -1.4 | 100% |
| FQ2 2025 (Jun 2025) | 0 | -0.0405 | -0.0405 | 100% |
| FQ1 2025 (Mar 2025) | -0.0531 | -0.0531 | 100% | |
| FQ4 2024 (Dec 2024) | -0.0337 | -0.0337 | 100% | |
| FQ3 2024 (Sep 2024) | -0.0338 | -0.0338 | 100% | |
| FQ2 2024 (Jun 2024) | -0.0395 | -0.0395 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0415 | -0.0415 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0354 | -0.0354 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.06B | $0.06B | $-0.13M | -0.2% |
| FQ2 2025 (Jun 2025) | $0.06B | $0.06B | $-0.13M | -0.21% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $0.06B | $61.26M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.06B | $61.06M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0.06B | $59.51M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.06B | $58.85M | 100% |